Tropical Journal of Pharmaceutical Research

Original Research Article | OPEN ACCESS

Erratum: Yiqi Huoxue Huatan formula attenuates inflammation in chronic obstructive pulmonary disease by suppressing the activation of PI3K/AKT and NF-κB signaling pathways

Hongtao Tan¹, Lingling Liu¹, Junxian Chen² , Yunchang Zhong¹, Yicong Li¹, Yiqun Li¹, Wei Zhang³

¹Department of Traditional Chinese Medicine, Huizhou Municipal Central Hospital, Huizhou, China; ²The First College of Clinical Medicine, Guangzhou University of Chinese Medicine, Guangzhou, China; ³Department of Pulmonary and Critical Care Medicine, The First Affiliated Hospital of Guangzhou University of Chinese Medicine, Guangzhou, China.

For correspondence:- Junxian Chen Email: Junx_ch@sina.cn Tel:+862036588233

Accepted: 5 January 2022 Published: 31 March 2022

Citation: Tan H, Liu L, Chen J, Zhong Y, Li Y, Li Y, et al. Erratum: Yiqi Huoxue Huatan formula attenuates inflammation in chronic obstructive pulmonary disease by suppressing the activation of PI3K/AKT and NF-κB signaling pathways. Trop J Pharm Res 2022; 21(3):679-679 doi: 10.4314/tjpr.v21i3.31

© 2022 The authors.
This is an Open Access article that uses a funding model which does not charge readers or their institutions for access and distributed under the terms of the Creative Commons Attribution License (http://creativecommons.org/licenses/by/4.0) and the Budapest Open Access Initiative (http://www.budapestopenaccessinitiative.org/read), which permit unrestricted use, distribution, and reproduction in any medium, provided the original work is properly credited..

Abstract

In the earlier published article, the affiliations of the authors were not properly identified, the telephone number and acknowledgement were incorrect and there was an omission in the statements under contribution of authors. The correct identification of authors’ affiliations is provided above and the other corrections are as follows:

Tel: +86-18620817501

Acknowledgement: This work was supported by 2022 Science and Research Project of Traditional Chinese Medicine Bureau of Guangdong Province (No.20221401), 2020 Special Fund for Health Care Development (Inheritance and Development of Traditional Chinese Medicine)-TCM Science and Research Project of Traditional Chinese Medicine Bureau of Guangdong Province (No.20201361), 2019 Huizhou Studio Development of Famous Doctor of Traditional Chinese Medicine Project (Huizhou Health [2019] No. 312).

Contribution of Authors: The authors declare that this work was done by the authors named in this article and all liabilities pertaining to claims relating to the content of this article will be borne by them. Hongtao Tan and Lingling Liu contributed equally to this work.

New citation: Tan H, Liu L, Chen J, Zhong Y, Li Y, Li Y, et al. Yiqi Huoxue Huatan formula attenuates inflammation in chronic obstructive pulmonary disease by suppressing the activation of PI3K/AKT and NF-κB signaling pathways. Trop J Pharm Res 2022; 21(1):45-52 doi: 10.4314/tjpr.v21i1.8. Erratum: 2022; 21(3): 579 doi: http://dx.doi.org/10.4314/tjpr.v 21i3.31

Earlier citation: Tan H, Liu L, Chen J, Zhong Y, Li Y, Li Y, et al. Yiqi Huoxue Huatan formula attenuates inflammation in chronic obstructive pulmonary disease by suppressing the activation of PI3K/AKT and NF-κB signaling pathways. Trop J Pharm Res 2022; 21(1):45-52 doi: 10.4314/tjpr.v21i1.8

Keywords: Yiqi Huoxue Huatan formula, COPD, PI3K/AKT signaling pathway, NF-?B signaling pathway